COR

CORTEX PHARMACEUTICALS INC

COR

Overview Fund Activity

Delisted

COR was delisted on the 11th of December, 2009.

Back to rankings

Healthcare Drug Manufacturers - General

Financial journalist opinion

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cencora, Inc. (NYSE:COR ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants James Cleary - Executive VP & CFO Bennett Murphy - Senior VP, Head of Investor Relations & Treasury Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good afternoon, everyone. Welcome to Day 3 of the Morgan Stanley Healthcare Conference.

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Cencora, Inc. (NYSE:COR ) Baird Global Healthcare Conference 2025 September 9, 2025 3:45 PM EDT Company Participants Bennett Murphy - Senior VP, Head of Investor Relations & Treasury James Cleary - Executive VP & CFO Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Presentation Eric Coldwell Senior Research Analyst All right.

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Cencora, Inc. (NYSE:COR ) Wells Fargo 20th Annual Healthcare Conference 2025 September 5, 2025 8:45 AM EDT Company Participants James Cleary - Executive VP & CFO Bennett Murphy - Senior VP, Head of Investor Relations & Treasury Conference Call Participants Stephen Baxter - Wells Fargo Securities, LLC, Research Division Presentation Stephen Baxter Senior Equity Analyst All right. Good morning, everyone.

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Zacks Investment Research

Here's Why You Should Hold Cencora Stock in Your Portfolio Now

COR gains from strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose risks.

Here's Why You Should Hold Cencora Stock in Your Portfolio Now

Zacks Investment Research

Here's Why Cencora (COR) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Cencora (COR) is a Strong Value Stock

Zacks Investment Research

COR vs. MEDP: Which Stock Is the Better Value Option?

Investors with an interest in Medical Services stocks have likely encountered both Cencora (COR) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?

COR vs. MEDP: Which Stock Is the Better Value Option?

Zacks Investment Research

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns

The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. GE, HWM, COR and CAKE are some such stocks.

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has appointed Lead Independent Director D. Mark Durcan as Chairman of the Board of Directors, effective October 1, 2025. Mr. Durcan will succeed Steven H. Collis, who has served as Cencora's Chairman since 2016 and previously served as Cencora's Chief Executive Officer from 2011 until 2024. As previously disclosed, Mr. Collis was elected to serve as Executive Chairman of the Board effective.

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Zacks Investment Research

Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why

Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.

Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why

Zacks Investment Research

Why Cencora (COR) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Cencora (COR) is a Top Value Stock for the Long-Term

See News Rankings

Charts implemented using Lightweight Charts™